热点追踪
HotTopics
[3]中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国Clin,2010,64(1):19-24.
甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,[15]GaoY,ChenM,YeH,etal.Long-termoutcomesofpatientswith
46(10):876-882.propylthiouracil-inducedanti-neutrophilcytoplasmicauto-antibody-
[4]IdeA,AminoN,KangS,etal.DifferentiationofpostpartumGraves''associatedvasculitis.Rheumatology(Oxford)[J].2008,47(10):1515-1520.
thyrotoxicosisfrompostpartumdestructivethyrotoxicosisusing[16]ErbilY,OzlukY,GirisM,etal.EffectofLugolsolutiononthyroidgland,
antithyrotropinreceptorantibodiesandthyroidbloodflow[J].Thyroid,blood?owandmicovesseldensityinpatientswithGraves''disease[J].J
2014,24(6):1027-1031.ClinEndocrinolMetab,2007,92(6):2182-2189.
[5]PedersenIB,KnudsenN,PerrildH,etal.TSH-receptorantibody[17]AnsaldoGL,PretolesiF,VaraldoE,etal.Dopplerevaluationofintrathyroid
measurementfordifferentiationofhyperthyroidismintoGraves''diseasearterialresistancesduringpreoperativetreatmentwithLugol’siodide
andmultinodulartoxicgoitre:acomparisonoftwocompetitivebindingsolutioninpatientswithdiffusetoxicgoiter[J].JAmCollSurg,2000,
assays[J].ClinEndocrinol(Oxf),2001,55(3):381-390.191(6):607-612.
[6]BurchHB,CooperDS.ManagementofGravesDisease:AReview[J].[18]YangY,HwangS,KimM,etal.RefractoryGraves''Disease
JAMA,2015,314(23):2544-2554.SuccessfullyCuredByAdjunctiveCholestyramineandSubsequentTotal
[7]VilchezFJ,TorresI,Garcia-ValeroA,etal.ConcomitantagranulocytosisThyroidectomy[J].EndocrinolMetab(Seoul),2015,30(4):620-625.
andhepatotoxicityaftertreatmentwithcarbimazole[J].AnnPharmacother,[19]GenserL,TresalletC,Godiris-PetitG,etal.Randomizedcontrolledtrialof
2006,40(11):2059-2063.alfacalcidolsupplementationforthereductionofhypocalcemiaaftertotal
[8]WoeberKA.Methimazole-inducedhepatotoxicity[J].EndocrPract,2002,thyroidectomy[J].AmJSurg,2014,207(1):39-45.
8(3):222-224.[20]TestaA,FantV,DeRosaA,etal.Calcitriolplushydrochlorothiazide
[9]RuizJK,RossiGV,VallejosHA,etal.Fulminanthepaticfailureassociatedpreventstransientpost-thyroidectomyhypocalcemia[J].HormMetabRes,
withpropylthiouracil[J].AnnPharmacother,2003,37(2):224-228.2006,38(12):821-826.
[10]RivkeesSA,SzarfmanA.Dissimilarhepatotoxicityprofilesof[21]AntakiaR,EdafeO,UttleyL,etal.Effectivenessofpreventativeandother
propylthiouracilandmethimazoleinchildren[J].JClinEndocrinolMetab,surgicalmeasuresonhypocalcemiafollowingbilateralthyroidsurgery:a
2010,95(7):3260-3267.systematicreviewandmeta-analysis[j].Thyroid,2015,25(1):95-106.
[11]WangMT,LeeWJ,HuangTY,etal.Antithyroiddrug-relatedhepatotoxicity[22]ShahM,BancosI,ThompsonGB,etal.TeriparatideTherapyandReduced
inhyperthyroidismpatients:apopulation-basedcohortstudy[J].BrJClinPostoperativeHospitalizationforPostsurgicalHypoparathyroidism[J].
Pharmacol,2014,78(3):619-629.JAMAOtolaryngolHeadNeckSurg,2015,141(9):822-827.
[12]YangJ,LiLF,XuQ,etal.Analysisof90casesofantithyroiddrug-induced[23]FDA2009U.S.FoodandDrugAdministrationinformationforhealthcare
severehepatotoxicityover13yearsinChina[J].Thyroid,2015,25(3):278-professionals--propylthiouracil-inducedliverfailure[EB/OL].Availableat:
283.www.fda.gov/Drugs/DrugSafety/PosrmarketDrugSafetyInformationforPati
[13]BalavoineAS,GlinoerD,DubucquoiS,etal.AntineutrophilCytoplasmicentsandProviders/ucm209023.htm,2016-01-19.
Antibody-PositiveSmall-VesselVasculitisAssociatedwithAntithyroid[24]AndersenSL,OlsenJ,CarleA,etal.Hyperthyroidismincidence
DrugTherapy:HowSigni?cantIstheClinicalProblem?[J].Thyroid,2015,?uctuateswidelyinandaroundpregnancyandisatvariancewithsome
25(12):1273-1281.otherautoimmunediseases:aDanishpopulation-basedstudy[J].JClin
[14]YazisizV,OngutG,TerziogluE,etal.ClinicalimportanceofantineutrophilEndocrinolMetab,2015,100(3):1164-1171.
cytoplasmicantibodypositivityduringpropylthiouraciltreatment[J].IntJ
[47]UKProspectiveDiabetesStudy(UKPDS)Group.Intensiveblood-glucosediabetes[J].NEnglJMed,2008,358(24):2545-2559.
controlwithsulphonylureasorinsulincomparedwithconventional[52]SimpsonSH,LeeJ,ChoiS,etal.Mortalityriskamongsulfonylureas:
treatmentandriskofcomplicationsinpatientswithtype2diabetes(UKPDSasystematicreviewandnetworkmeta-analysis[J].LancetDiabetes
33)[J].Lancet,1998,352(9131):837-853.Endocrinol,2015,3(1):43-51.
[48]AbrairaC,DuckworthW,McCarrenM,etal.Designofthecooperative[53]KhalangotM,TronkoM,KravchenkoV,etal.Glibenclamide-related
studyonglycemiccontrolandcomplicationsindiabetesmellitustype2:excessintotalandcardiovascularmortalityrisks:datafromlargeUkrainian
VeteransAffairsDiabetesTrial[J].JDiabetesComplications,2003,17(6):observationalcohortstudy[J].DiabetesResClinPract,2009,86(3):247-
314-322.253.
[49]DuckworthW,AbrairaC,MoritzT,etal.Glucosecontrolandvascular[54]LiuSY,TianHM,LiaoDQ,etal.TheeffectofgliquidoneonKATP
complicationsinveteranswithtype2diabetes[J].NEnglJMed,2009,channelsinpancreaticβ-cells,cardiomyocytes,andvascularsmoothmuscle
360(2):129-139.cells[J].DiabetesResClinPract,2015,109(2):334-339.
[50]KahnSE,HaffnerSM,HeiseMA,etal.Glycemicdurabilityof[55]HolmanRR.Long-termefficacyofsulfonylureas:aUnitedKingdom
rosiglitazone,metformin,orglyburidemonotherapy[J].NEnglJMed,ProspectiveDiabetesStudyperspective[J].Metabolism,2006,55(5
2006,355(23):2427-2443.Suppl1):S2-5.
[51]ActiontoControlCardiovascularRiskinDiabetesStudyGroup,Gerstein[56]安雅莉,高妍,朱倩,等.中国新诊断2型糖尿病胰岛素分泌和胰岛素抵
HC,MillerME,etal.Effectsofintensiveglucoseloweringintype2抗特点调查[J].中华内分泌代谢杂志,2008,24:256-260.
药品评价2017年第14卷第1期
17 |
|
